Results 91 to 100 of about 27,037 (216)

Plasma Protein Binding Structure–Activity Relationships Related to the N-Terminus of Daptomycin

open access: yes, 2017
Daptomycin is a lipopeptide antibiotic that is highly bound to plasma proteins. To date, the plasma components and structure–activity relationships responsible for the plasma protein binding profile of daptomycin remain uncharacterized.
Yan Zhu   +21 more
core   +1 more source

A daptomycin biotechnológiai úton történő előállítása

open access: yes, 2013
A daptomycin, egy lipopeptid antibiotikum bemutatása és fermentáció általi előállításának ismertetése. Szó esik a dolgozatban a gyártáshoz használt Streptomyces roseosporusról és rövid ismertetése is megtörténik.
Kerekes, Fanni
core  

Multi-strain Tn-Seq reveals common daptomycin resistance determinants in Staphylococcus aureus

open access: yesPLoS Pathogens, 2019
Antibiotic-resistant Staphylococcus aureus remains a leading cause of antibiotic resistance-associated mortality in the United States. Given the reality of multi-drug resistant infections, it is imperative that we establish and maintain a pipeline of new
Kathryn A. Coe   +6 more
semanticscholar   +1 more source

Daptomycin–β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis [PDF]

open access: yes, 2016
Beta-lactams enhance the in vitro activity of daptomycin against methicillin-resistant strains of Staphylococcus aureus Experiments were performed in a rabbit model of aortic valve endocarditis caused by methicillin-resistant daptomycin-nonsusceptible S.
Hamilton, Stephanie M   +4 more
core   +1 more source

Daptomycin-Nonsusceptible, Vancomycin-Intermediate, Methicillin-Resistant Staphylococcus aureus Endocarditis

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2012
Due to the emergence of Staphylococcus aureus with reduced vancomycin susceptibility, newer antibiotics, including daptomycin, have been used to treat methicillin-resistant S aureus infections. Daptomycin is a cyclic lipopeptide that is approved to treat
Ryan Yu   +4 more
doaj   +1 more source

Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains

open access: yesApplied Microbiology and Biotechnology, 2020
Daptomycin is a last resort antibiotic for the treatment of infections caused by many Gram-positive bacterial strains, including vancomycin-resistant Enterococcus (VRE) and methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA ...
Erin M. Scull   +7 more
semanticscholar   +1 more source

Development of pilot plant fermentation in the pharmaceutical industry – active pharmaceutical ingredient: Daptomycin

open access: yes, 2016
A daptomycin nevű antibiotikum termeltetésének kísérleti üzemi léptékű fejlesztése, a technológia optimalizálása. A dolgozat célkitűzése volt: a technológia reprezentatív módon történő bemutatása, a daptomycin kihozatalának növelése, a hatóanyag mellett ...
Anga, Csilla
core  

Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose

open access: yes, 2017
Treatment options for vancomycin-resistant enterococci (VRE) bloodstream infection are limited. Studies comparing daptomycin or linezolid in treating VRE bloodstream infection have conflicting results and suggest daptomycin underdosing.
Chuang, Y-C.;Lin, H-Y.;Chen, P-Y.;Lin, C-Y.;Wang, J-T.;Chang, S-C.   +1 more
core   +1 more source

Defective pgsA contributes to increased membrane fluidity and cell wall thickening in Staphylococcus aureus with high-level daptomycin resistance

open access: yesmSphere
Daptomycin is a membrane-targeting last-resort antimicrobial therapeutic for the treatment of infections caused by methicillin- and/or vancomycin-resistant Staphylococcus aureus. In the rare event of failed daptomycin therapy, the source of resistance is
Christian D. Freeman   +5 more
doaj   +1 more source

Daptomycin for Pediatric Gram-Positive Acute Hematogenous Osteomyelitis

open access: yesThe Pediatric Infectious Disease Journal, 2020
Supplemental Digital Content is available in the text. Background: We prospectively evaluated efficacy and safety of daptomycin versus active comparator in children with acute hematogenous osteomyelitis (AHO).
J. Bradley   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy